As we have no manufacturing ready and patents stop in 2018. $2.20 for a hep C cure would be about right. Double the SP now. Thats what some people seem to think here anyway.
Week 37 Wrap: HotCopper likes Cuban oil; markets shrug debate off for Putin; firebrand quant says social media a market threat